NAA40 and colorectal cancer: Hence, our results strongly favor the idea that NAA40 is a critical mediator at the interface between epigenetics and metabolism by linking one-carbon cycle to drug response and signify its potential as a novel predictive factor and therapeutic target in colorectal cancer.